Skip to main content
Premium Trial:

Request an Annual Quote

Medical University of South Carolina Cashes in on Lotto

NEW YORK, June 25 – The Medical University of South Carolina yesterday received $11 million in South Carolina funding, of which $7 million will go to programs in genomics and proteomics.

The state's nine-member Centers of Excellence Review Board yesterday carved up $30 million in lottery proceeds for six specialized research projects that are seen as stimuli for economic development in high technology. The program, the endowed chairs fund, is a four-year effort funded for $30 million each year. The first-year committee will allocate another $30 million after the fiscal year begins July 1.

The awarded programs will have to raise matching funds to qualify for the money.

The Medical University at Charleston will receive $4 million for a marine genomics project, $4 million for proteomics research, and $3 million for neuroscience research.

The funding will endow at least two professorships for MUSC’s Research Center of Economic Excellence in Applied Marine Genomics. The center will use genomics tools to research disease resistance and infection in aquatic species, as well as pathogen detection, and the development of diagnostic tools. The center will collaborate with Clemson University’s Genome Institute and the College of Charleston’s marine biology and environmental science graduate programs.

Another $4 million will go to the school’s proteomics research center, which is already receiving $15 million as one of 10 labs nationally developed with NIH funding.

The largest share of the funding -- $15 million -- went to the proposed International Center for Automotive Research at Clemson University, which already has a $10 million pledge of support from automaker BMW.

 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.